These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32171923)

  • 1. Brain volume loss in individuals over time: Source of variance and limits of detectability.
    Narayanan S; Nakamura K; Fonov VS; Maranzano J; Caramanos Z; Giacomini PS; Collins DL; Arnold DL
    Neuroimage; 2020 Jul; 214():116737. PubMed ID: 32171923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-dependent cut-offs for pathological deep gray matter and thalamic volume loss using Jacobian integration.
    Opfer R; Krüger J; Spies L; Hamann M; Wicki CA; Kitzler HH; Gocke C; Silva D; Schippling S
    Neuroimage Clin; 2020; 28():102478. PubMed ID: 33269702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis.
    Fritz DA; Dwyer MG; Bagnato F; Watts KL; Bratina A; Zorzon M; Durastanti V; Locatelli L; Millefiorini E; Zivadinov R
    Neurol Res; 2006 Apr; 28(3):275-9. PubMed ID: 16687053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.
    Andorra M; Nakamura K; Lampert EJ; Pulido-Valdeolivas I; Zubizarreta I; Llufriu S; Martinez-Heras E; Sola-Valls N; Sepulveda M; Tercero-Uribe A; Blanco Y; Saiz A; Villoslada P; Martinez-Lapiscina EH
    JAMA Neurol; 2018 Oct; 75(10):1246-1255. PubMed ID: 29971335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging and Brain Atrophy in Multiple Sclerosis.
    Ghione E; Bergsland N; Dwyer MG; Hagemeier J; Jakimovski D; Paunkoski I; Ramasamy DP; Carl E; Hojnacki D; Kolb C; Weinstock-Guttman B; Zivadinov R
    J Neuroimaging; 2019 Jul; 29(4):527-535. PubMed ID: 31074192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease modeling in multiple sclerosis: assessment and quantification of sources of variability in brain parenchymal fraction measurements.
    Sampat MP; Healy BC; Meier DS; Dell'Oglio E; Liguori M; Guttmann CR
    Neuroimage; 2010 Oct; 52(4):1367-73. PubMed ID: 20362675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes.
    Jakimovski D; Zivadinov R; Bergsland N; Ramasamy DP; Hagemeier J; Genovese AV; Hojnacki D; Weinstock-Guttman B; Dwyer MG
    Neuroimage Clin; 2021; 29():102554. PubMed ID: 33472143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
    Uher T; Krasensky J; Vaneckova M; Sobisek L; Seidl Z; Havrdova E; Bergsland N; Dwyer MG; Horakova D; Zivadinov R
    J Neuroimaging; 2017 Nov; 27(6):620-629. PubMed ID: 28464417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis.
    Guo C; Ferreira D; Fink K; Westman E; Granberg T
    Eur Radiol; 2019 Mar; 29(3):1355-1364. PubMed ID: 30242503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine.
    Ghione E; Bergsland N; Dwyer MG; Hagemeier J; Jakimovski D; Paunkoski I; Ramasamy DP; Silva D; Carl E; Hojnacki D; Kolb C; Weinstock-Guttman B; Zivadinov R
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2237-2242. PubMed ID: 30467212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy.
    Steenwijk MD; Amiri H; Schoonheim MM; de Sitter A; Barkhof F; Pouwels PJW; Vrenken H
    Neuroimage Clin; 2017; 15():843-853. PubMed ID: 28794970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis.
    Dwyer MG; Silva D; Bergsland N; Horakova D; Ramasamy D; Durfee J; Vaneckova M; Havrdova E; Zivadinov R
    Neuroimage Clin; 2017; 15():769-779. PubMed ID: 28706852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX.
    Jasperse B; Valsasina P; Neacsu V; Knol DL; De Stefano N; Enzinger C; Smith SM; Ropele S; Korteweg T; Giorgio A; Anderson V; Polman CH; Filippi M; Miller DH; Rovaris M; Barkhof F; Vrenken H;
    J Magn Reson Imaging; 2007 Oct; 26(4):881-5. PubMed ID: 17896359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.
    Paolillo A; Piattella MC; Pantano P; Di Legge S; Caramia F; Russo P; Lenzi GL; Pozzilli C
    J Neurol; 2004 Apr; 251(4):432-9. PubMed ID: 15083288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis.
    Uher T; Krasensky J; Sobisek L; Seidl Z; Bergsland N; Dwyer MG; Kubala Havrdova E; Zivadinov R; Horakova D; Vaneckova M
    J Neuroimaging; 2018 May; 28(3):328-337. PubMed ID: 29485230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating and accounting for the effect of MRI scanner changes on longitudinal whole-brain volume change measurements.
    Lee H; Nakamura K; Narayanan S; Brown RA; Arnold DL;
    Neuroimage; 2019 Jan; 184():555-565. PubMed ID: 30253207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice - comparison of 1.5 and 3 Tesla magnetic resonance imaging.
    Lysandropoulos AP; Absil J; Metens T; Mavroudakis N; Guisset F; Van Vlierberghe E; Smeets D; David P; Maertens A; Van Hecke W
    Brain Behav; 2016 Feb; 6(2):e00422. PubMed ID: 27110445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined analysis of global and compartmental brain volume changes in early multiple sclerosis in clinical practice.
    Pichler A; Khalil M; Langkammer C; Pinter D; Bachmaier G; Ropele S; Fuchs S; Enzinger C; Fazekas F
    Mult Scler; 2016 Mar; 22(3):340-6. PubMed ID: 26163072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
    Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
    J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salient Central Lesion Volume: A Standardized Novel Fully Automated Proxy for Brain FLAIR Lesion Volume in Multiple Sclerosis.
    Dwyer MG; Bergsland N; Ramasamy DP; Weinstock-Guttman B; Barnett MH; Wang C; Tomic D; Silva D; Zivadinov R
    J Neuroimaging; 2019 Sep; 29(5):615-623. PubMed ID: 31259467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.